Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...

The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...

A digital toolkit with patient scripts, risk calculator comparisons and more could help primary care and OB/GYN providers ...

Three bright blue dogs spotted outside the Chernobyl nuclear plant in October 2024 triggered a global wave of speculation that quickly outpaced the facts. Photos of the animals, roaming near the edge ...

A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...

Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...

A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch ...

Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

Broadcast Retirement Network's Jeffrey Snyder discusses improving autism evaluation and diagnosis with Dr. Bahar Tungenc of ...

Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.